These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 33971027)

  • 21. Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis.
    Götzl JK; Mori K; Damme M; Fellerer K; Tahirovic S; Kleinberger G; Janssens J; van der Zee J; Lang CM; Kremmer E; Martin JJ; Engelborghs S; Kretzschmar HA; Arzberger T; Van Broeckhoven C; Haass C; Capell A
    Acta Neuropathol; 2014; 127(6):845-60. PubMed ID: 24619111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FTLD-TDP assemblies seed neoaggregates with subtype-specific features via a prion-like cascade.
    De Rossi P; Lewis AJ; Furrer J; De Vos L; Demeter T; Zbinden A; Zhong W; Wiersma VI; Scialo C; Weber J; Guo Z; Scaramuzza S; Di Fabrizio M; Böing C; Castaño-Díez D; Al-Amoudi A; Pérez-Berlanga M; Lashley T; Stahlberg H; Polymenidou M
    EMBO Rep; 2021 Dec; 22(12):e53877. PubMed ID: 34806807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reappraisal of TDP-43 pathology in FTLD-U subtypes.
    Mackenzie IR; Neumann M
    Acta Neuropathol; 2017 Jul; 134(1):79-96. PubMed ID: 28466142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP.
    Arseni D; Chen R; Murzin AG; Peak-Chew SY; Garringer HJ; Newell KL; Kametani F; Robinson AC; Vidal R; Ghetti B; Hasegawa M; Ryskeldi-Falcon B
    Nature; 2023 Aug; 620(7975):898-903. PubMed ID: 37532939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence of cerebellar TDP-43 loss of function in FTLD-TDP.
    Pickles S; Gendron TF; Koike Y; Yue M; Song Y; Kachergus JM; Shi J; DeTure M; Thompson EA; Oskarsson B; Graff-Radford NR; Boeve BF; Petersen RC; Wszolek ZK; Josephs KA; Dickson DW; Petrucelli L; Cook CN; Prudencio M
    Acta Neuropathol Commun; 2022 Jul; 10(1):107. PubMed ID: 35879741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study.
    Kuiperij HB; Versleijen AA; Beenes M; Verwey NA; Benussi L; Paterlini A; Binetti G; Teunissen CE; Raaphorst J; Schelhaas HJ; Küsters B; Pijnenburg YA; Ghidoni R; Verbeek MM
    J Alzheimers Dis; 2017; 55(2):585-595. PubMed ID: 27662293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U.
    Tsai KJ; Yang CH; Fang YH; Cho KH; Chien WL; Wang WT; Wu TW; Lin CP; Fu WM; Shen CK
    J Exp Med; 2010 Aug; 207(8):1661-73. PubMed ID: 20660618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurocognitive speed associates with frontotemporal lobar degeneration TDP-43 subtypes.
    Dean PM; Smith GE; Parisi JE; Dickson DW; Petersen RC; Josephs KA
    J Clin Neurosci; 2013 Dec; 20(12):1737-41. PubMed ID: 24012243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pathological phenotypes of human TDP-43 transgenic mouse models are independent of downregulation of mouse Tdp-43.
    Xu YF; Prudencio M; Hubbard JM; Tong J; Whitelaw EC; Jansen-West K; Stetler C; Cao X; Song J; Zhang YJ
    PLoS One; 2013; 8(7):e69864. PubMed ID: 23922830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43.
    Walker AK; Spiller KJ; Ge G; Zheng A; Xu Y; Zhou M; Tripathy K; Kwong LK; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2015 Nov; 130(5):643-60. PubMed ID: 26197969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration?
    Whitwell JL; Jack CR; Parisi JE; Senjem ML; Knopman DS; Boeve BF; Rademakers R; Baker M; Petersen RC; Dickson DW; Josephs KA
    Neurology; 2010 Dec; 75(24):2212-20. PubMed ID: 21172844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
    Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
    Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential Neurotoxicity Related to Tetracycline Transactivator and TDP-43 Expression in Conditional TDP-43 Mouse Model of Frontotemporal Lobar Degeneration.
    Kukreja L; Shahidehpour R; Kim G; Keegan J; Sadleir KR; Russell T; Csernansky J; Mesulam M; Vassar RJ; Wang L; Dong H; Geula C
    J Neurosci; 2018 Jul; 38(27):6045-6062. PubMed ID: 29807909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptomic analysis of frontotemporal lobar degeneration with TDP-43 pathology reveals cellular alterations across multiple brain regions.
    Hasan R; Humphrey J; Bettencourt C; Newcombe J; ; Lashley T; Fratta P; Raj T
    Acta Neuropathol; 2022 Mar; 143(3):383-401. PubMed ID: 34961893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series.
    Kim EJ; Brown JA; Deng J; Hwang JL; Spina S; Miller ZA; DeMay MG; Valcour V; Karydas A; Ramos EM; Coppola G; Miller BL; Rosen HJ; Seeley WW; Grinberg LT
    J Neurol; 2018 Dec; 265(12):2960-2971. PubMed ID: 30324308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice.
    Igaz LM; Kwong LK; Lee EB; Chen-Plotkin A; Swanson E; Unger T; Malunda J; Xu Y; Winton MJ; Trojanowski JQ; Lee VM
    J Clin Invest; 2011 Feb; 121(2):726-38. PubMed ID: 21206091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frontotemporal Dementia: Correlations Between Psychiatric Symptoms and Pathology.
    Scarioni M; Gami-Patel P; Timar Y; Seelaar H; van Swieten JC; Rozemuller AJM; Dols A; Scarpini E; Galimberti D; ; Hoozemans JJM; Pijnenburg YAL; Dijkstra AA
    Ann Neurol; 2020 Jun; 87(6):950-961. PubMed ID: 32281118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration.
    Wegorzewska I; Bell S; Cairns NJ; Miller TM; Baloh RH
    Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18809-14. PubMed ID: 19833869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laminar distribution of the pathological changes in sporadic frontotemporal lobar degeneration with transactive response (TAR) DNA-binding protein of 43 kDa (TDP-43) proteinopathy: a quantitative study using polynomial curve fitting.
    Armstrong RA; Hamilton RL; Mackenzie IR; Hedreen J; Cairns NJ
    Neuropathol Appl Neurobiol; 2013 Jun; 39(4):335-47. PubMed ID: 22804696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intracellular seeded aggregation of TDP-43].
    Nonaka T; Hasegawa M
    Rinsho Shinkeigaku; 2012; 52(11):1056-8. PubMed ID: 23196514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.